These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2779752)

  • 1. Serotonin-antagonist effects of 1-(1-naphthyl)piperazine on operant behavior of squirrel monkeys.
    McKearney JW
    Neuropharmacology; 1989 Aug; 28(8):817-21. PubMed ID: 2779752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of serotonin agonists on operant behavior in the squirrel monkey: quipazine, MK-212, trifluoromethylphenylpiperazine, and chlorophenylpiperazine.
    McKearney JW
    Pharmacol Biochem Behav; 1990 Jan; 35(1):181-5. PubMed ID: 2315357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of serotonin receptor agonists and antagonists on schedule-controlled behavior of squirrel monkeys.
    Brady LS; Barrett JE
    J Pharmacol Exp Ther; 1985 Nov; 235(2):436-41. PubMed ID: 2932546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability in the effects of 4-bromo-2,5-dimethoxyamphetamine (DOB) on operant behavior of squirrel monkeys.
    McKearney JW
    Pharmacol Biochem Behav; 1988 Feb; 29(2):281-5. PubMed ID: 3362922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The quipazine- and TFMPP-increased conditioned avoidance response in rats: role of 5HT1C/5-HT2 receptors.
    Alhaider AA; Ageel AM; Ginawi OT
    Neuropharmacology; 1993 Dec; 32(12):1427-32. PubMed ID: 8152532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
    Titeler M; Lyon RA; Davis KH; Glennon RA
    Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of serotonin receptor antagonists on punished responding maintained by stimulus-shock termination or food presentation in squirrel monkeys.
    Brady LS; Barrett JE
    J Pharmacol Exp Ther; 1985 Jul; 234(1):106-12. PubMed ID: 4009495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of some 1-arylpiperazines as antagonists of stereotyped behaviors mediated by central serotonergic receptors in rodents.
    Simansky KJ; Schechter LE
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1073-81. PubMed ID: 3144595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT1 and 5-HT2 binding characteristics of some quipazine analogues.
    Glennon RA; Slusher RM; Lyon RA; Titeler M; McKenney JD
    J Med Chem; 1986 Nov; 29(11):2375-80. PubMed ID: 3783595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.
    Glennon RA; Young R; Rosecrans JA
    Eur J Pharmacol; 1983 Jul; 91(2-3):189-96. PubMed ID: 6617740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent antinociceptive properties of piperazine-type serotonin agonists: trifluoromethylphenylpiperazine, chlorophenylpiperazine, and MK-212.
    McKearney JW
    Pharmacol Biochem Behav; 1989 Mar; 32(3):657-60. PubMed ID: 2740421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism by ketanserin of the behavioral effects of quipazine but not l-5-hydroxytryptophan in squirrel monkeys.
    Witkin JM; Brady LS; Barrett JE
    Psychopharmacology (Berl); 1988; 94(3):302-5. PubMed ID: 3128804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors.
    Kennett GA; Curzon G
    Psychopharmacology (Berl); 1988; 96(1):93-100. PubMed ID: 2906446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine.
    Fiorella D; Helsley S; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 Dec; 122(3):237-43. PubMed ID: 8748393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors.
    Conn PJ; Sanders-Bush E
    J Pharmacol Exp Ther; 1987 Aug; 242(2):552-7. PubMed ID: 3039120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for involvement of 5-hydroxytryptamine1 receptors in antidepressant-like drug effects on differential-reinforcement-of-low-rate 72-second behavior.
    Marek GJ; Li AA; Seiden LS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):60-71. PubMed ID: 2746511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour.
    Body S; Asgari K; Rickard JF; Zhang Z; Fone KC; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2005 Sep; 181(2):289-98. PubMed ID: 15864559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP).
    Callahan PM; Cunningham KA
    Eur J Pharmacol; 1994 May; 257(1-2):27-38. PubMed ID: 8082704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral effects of cocaine alone and in combination with selective dopamine antagonists in the squirrel monkey.
    Katz JL; Witkin JM
    Psychopharmacology (Berl); 1991; 103(1):33-40. PubMed ID: 2006242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible 5-hydroxytryptamine1 (5-HT1) receptor involvement in the stimulus properties of 1-(m-trifluoromethylphenyl)piperazine (TFMPP).
    Cunningham KA; Appel JB
    J Pharmacol Exp Ther; 1986 May; 237(2):369-77. PubMed ID: 2939233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.